Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | CNR2 | P34972 | 4/20 | 0.36 |
| ▸ | SCARB1 | Q8WTV0 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.35 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.35 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.35 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.35 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.35 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12597391 | 0.96 | ALDH1A1 (0.42) | ALDH1A1MAPK1TSHRHPGDNPC1 | |
| SCHEMBL18807690 | 0.94 | ALDH1A1 (0.46) | ALDH1A1MAPK1TSHRHPGDNPC1 | |
| SCHEMBL1979651 | 0.91 | ALDH1A1 (0.47) | ALDH1A1MAPK1HPGDNPC1KDM4E | |
| SCHEMBL18807691 | 0.91 | ALDH1A1 (0.39) | ALDH1A1MAPK1TSHRHPGDNPC1 | |
| SCHEMBL1978488 | 0.88 | CNR2 (0.52) | ALDH1A1MAPK1TSHRHPGDNPC1 | |
| SCHEMBL14212160 | 0.88 | ALDH1A1 (0.37) | ALDH1A1MAPK1TSHRHPGDNPC1 | |
| SCHEMBL12596931 | 0.85 | CNR2 (0.40) | ALDH1A1MAPK1TSHRHPGDNPC1 | |
| SCHEMBL13640282 | 0.84 | KDM4E (0.38) | ALDH1A1MAPK1TSHRHPGDNPC1 | |
| SCHEMBL13640699 | 0.83 | ALDH1A1 (0.39) | ALDH1A1MAPK1TSHRHPGDNPC1 | |
| SCHEMBL12596941 | 0.82 | ALDH1A1 (0.37) | ALDH1A1MAPK1TSHRHPGDNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170121529-A1 | SOLVENT RESISTANT POLYMERIC MEMBRANES | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2017-05-04 | — | — | US | disclosed |
| US-20150291843-A1 | SOLVENT RESISTANT POLYMERIC MEMBRANES | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2015-10-15 | — | — | US | disclosed |
| US-8957224-B2 | Photoinitiators for UV-LED curable compositions and inks | AGFA GRAPHICS NV (BE) | 2015-02-17 | — | — | US | disclosed |
| US-8569393-B2 | UV-LED curable compositions and inks | AGFA-GEVAERT N.V. (BE) | 2013-10-29 | — | — | US | disclosed |
| US-20120309861-A1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT N.V. (BE) | 2012-12-06 | — | — | US | disclosed |
| US-20120283349-A1 | UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT N.V. (BE) | 2012-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120309861-A1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | WEE1, CBX4, USP9X | ALDH1A1 1029/4885MAPK1 4340/4885TSHR 4726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.